-
Featured
Advanced Technology Improves Cervical Spine Surgery Outcomes
Surgeons in Massachusetts General Hospital's Neurosurgical Spine Service use a multidisciplinary approach to treat cervical spine deformities with complex surgeries using innovative technology including artificial intelligence.
-
Featured
Finding New Approaches to Treat Desmoid Tumor Patients
Surgery for desmoid tumors is only about 50% effective. Multidisciplinary care may be more effective for helping patients find relief.
-
Adding High-Dose Radiation to Surgery Confers Survival Benefit in Patients With Chordoma
Daniel G. Tobert, MD, Joseph H. Schwab, MD, MS, and colleagues demonstrated that adding photon and/or proton radiation therapy (≥70 Gy) to surgical excision of chordoma was associated with 72% less risk of death and 77% less risk of local recurrence within five years.
-
Estimating the Survival of Patients With Spinal Metastasis
Using an online survey, Quirina Thio, Joseph Schwab, MD, and colleagues documented poor agreement between surgeons who were asked to estimate survival for 12 patients with spinal metastasis. There was also a substantial discrepancy between the surgeons' estimates and the patients' actual survival.
-
Prophylactic Stabilization of Impending Fracture Improves Survival in Patients With Long Bone Metastases
Orthopedic oncology researchers at Massachusetts General Hospital found that, for patients who have a long bone metastatic lesion at substantial risk of fracture, prophylactic fixation is associated with a 28% greater chance of one-year survival and other benefits, versus stabilizing a completed pathological fracture.
-
NASS 2021: Controversies and Current Issues in Spinal Cord Tumors
As part of the North American Spine Society (NASS) 2021 annual conference, Joseph H. Schwab, MD, chief of the Orthopaedic Spine Center, discussed controversies and current issues in spinal cord tumors.
Mass General Cancer Center Contributors
-
Erik T. Newman, MD
Orthopaedic Oncology Surgeon, Department of Orthopaedics, Massachusetts General Hospital, Instructor in Orthopaedic Surgery, Harvard Medical School
Recent Article
Minimal Clinically Important Differences for Lower Extremity Metastatic Surgery -
John H. Shin, MD
Director, Spinal Deformity and Spine Oncology (Mass General Cancer Center), Spinal Reconstruction Surgery
Recent Article
Review: Novel Applications of Spinal Navigation in Deformity and Oncology Surgery
-
Joseph H. Schwab, MD, MS
Chief, Orthopaedic Spine Surgery, Director, Spine Oncology & Co-Director, Stephen L. Harris Chordoma Center, Associate Professor of Orthopaedic Surgery, Harvard Medical School
Recent Article
Adding High-Dose Radiation to Surgery Confers Survival Benefit in Patients With Chordoma
-
Kevin Andrew Raskin, MD
Chief, Orthopaedic Oncology Service, Program Director, Musculoskeletal Oncology Fellowship Program, Massachusetts General Hospital, Assistant Professor of Orthopaedic Surgery, Harvard Medical School
Recent Article
Nutritional, Physiological Factors Affect Wound Infection After Surgery for Lower-Extremity Soft Tissue Sarcoma
-
Santiago A. Lozano-Calderon, MD, PhD
Orthopaedic Oncology Surgeon, Assistant Professor, Orthopaedic Surgery, Harvard Medical School
Recent Article
Nutritional, Physiological Factors Affect Wound Infection After Surgery for Lower-Extremity Soft Tissue Sarcoma
Orthopaedic Oncology Service at Mass General
As members of the Cancer Center at Massachusetts General Hospital, the Orthopaedic Oncology team provides compassionate care to children, adolescents and adults with primary bone and soft tissue tumors (benign and malignant) and metastatic.
